Publication | Open Access
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)
50
Citations
16
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1